as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
0.91%
Downside
2.74%
Upside
52 Week's Low
52 Week's High
25.18%
Downside
324.66%
Upside
Check Iovance Biotherapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$873.3M
EPS (TTM)
-1.0786
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-375.8M
Revenue (TTM)
250.4M
Profit Margin
-158.78%
Return On Equity TTM
-53.89%
Compare market cap, revenue, PE, and other key metrics of Iovance Biotherapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $873.3M | -94.9% | NA | -158.78% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The Iovance Biotherapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Iovance Biotherapeutics, Inc. investment value today
Current value as on today
₹30,191
Returns
Returns from Iovance Biotherapeutics, Inc. Stock
Dollar Returns*
₹5,939 (+5.94%)
Based on 20 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 20 analysts, 90% of analysts recommend a 'BUY' rating for Iovance Biotherapeutics, Inc.. Average target price of $8.25
Get share price movements and forecasts by analysts on Iovance Biotherapeutics, Inc..
What analysts predicted
73.45%UPSIDE
Target Price
$8.25
Current Price
$2.19
Analyzed by
20 Analysts
Target
$8.25
Iovance Biotherapeutics, Inc. target price $8.25, a slight upside of 73.45% compared to current price of $2.19. According to 20 analysts rating.
Investment in Iovance Biotherapeutics, Inc. Shares on INDmoney has dropped by -29.50% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Iovance Biotherapeutics, Inc. Stock has increased by 443% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:443% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 246.2%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 977.7% return, outperforming this stock by 1047.4%
Price Dip
![]()
In the last 7 days, IOVA stock has moved down by -10.9%
| Organisation | Iovance Biotherapeutics, Inc. |
| Headquarters | 825 Industrial Road, San Carlos, CA, United States, 94070 |
| Industry | Health Technology |
| CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Corleen M. Roche | Chief Financial Officer |
Mr. Matthew W. Rosinack | Principal Accounting Officer |
Ms. Tracy Winton | Executive Vice President of Human Resources |
Mr. Brian Shew M.B.A. | Senior VP & Head of Digital and Information Technology |
Dr. Frederick G. Vogt Esq., J.D., Ph.D. | Interim CEO, President, General Counsel, Corporate Secretary & Director |
Dr. Igor P. Bilinsky Ph.D. | Chief Operating Officer |
Dr. Friedrich Graf Finckenstein M.D. | Chief Medical Officer |
Dr. Raj K. Puri M.D., Ph.D. | Chief Regulatory Officer |
Ms. Sara Pellegrino | Senior Vice President of Investor Relations & Corporate Communications |
Mr. Howard B. Johnson M.B.A. | Chief Business Officer |
Iovance Biotherapeutics, Inc. share price today is $2.19 as on at the close of the market. Iovance Biotherapeutics, Inc. share today touched a day high of $2.25 and a low of $2.17.
Iovance Biotherapeutics, Inc. share touched a 52 week high of $9.3 on and a 52 week low of $1.64 on . Iovance Biotherapeutics, Inc. stock price today i.e. is closed at $2.19,which is 76.45% down from its 52 week high and 33.66% up from its 52 week low.
Iovance Biotherapeutics, Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Iovance Biotherapeutics, Inc. (IOVA) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Iovance Biotherapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Iovance Biotherapeutics, Inc. share’s latest price of $2.19 as on December 6, 2025 at 2:29 am IST, you will get 4.5662 shares of Iovance Biotherapeutics, Inc.. Learn more about
fractional shares .
Iovance Biotherapeutics, Inc. stock has given -94.9% share price returns and 21.76% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?